Lumos Diagnostics Holdings (ASX:LDX) Net Margin % : -231.87% (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Lumos Diagnostics Holdings Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Lumos Diagnostics Holdings's Net Income for the six months ended in Dec. 2023 was A$-9.58 Mil. Lumos Diagnostics Holdings's Revenue for the six months ended in Dec. 2023 was A$4.13 Mil. Therefore, Lumos Diagnostics Holdings's net margin for the quarter that ended in Dec. 2023 was -231.87%.

The historical rank and industry rank for Lumos Diagnostics Holdings's Net Margin % or its related term are showing as below:

ASX:LDX' s Net Margin % Range Over the Past 10 Years
Min: -393.17 Med: -239.17 Max: -85.16
Current: -107.49

ASX:LDX's Net Margin % is ranked worse than
73.3% of 221 companies
in the Medical Diagnostics & Research industry
Industry Median: -12.37 vs ASX:LDX: -107.49

Lumos Diagnostics Holdings Net Margin % Historical Data

The historical data trend for Lumos Diagnostics Holdings's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lumos Diagnostics Holdings Net Margin % Chart

Lumos Diagnostics Holdings Annual Data

Trend

Jun22

Jun23

Net Margin %

-393.17

-85.16

Lumos Diagnostics Holdings Semi-Annual Data
	Dec20	Dec21	Jun22	Dec22	Jun23	Dec23
Net Margin %	Get a 7-Day Free Trial			-213.14	-479.54	-129.04	-44.17	-231.87

Competitive Comparison of Lumos Diagnostics Holdings's Net Margin %

For the Diagnostics & Research subindustry, Lumos Diagnostics Holdings's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Lumos Diagnostics Holdings's Net Margin % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Lumos Diagnostics Holdings's Net Margin % distribution charts can be found below:

* The bar in red indicates where Lumos Diagnostics Holdings's Net Margin % falls into.

Lumos Diagnostics Holdings Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Lumos Diagnostics Holdings's Net Margin for the fiscal year that ended in Jun. 2023 is calculated as

Net Margin	=	Net Income (A: Jun. 2023 )	/	Revenue (A: Jun. 2023 )
	=	-13.367	/	15.697
	=	-85.16 %

Lumos Diagnostics Holdings's Net Margin for the quarter that ended in Dec. 2023 is calculated as

Net Margin	=	Net Income (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	-9.581	/	4.132
	=	-231.87 %

Lumos Diagnostics Holdings (ASX:LDX) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Lumos Diagnostics Holdings Net Margin % Related Terms

Thank you for viewing the detailed overview of Lumos Diagnostics Holdings's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Lumos Diagnostics Holdings (ASX:LDX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Lumos Diagnostics Holdings Ltd (ASX:LDX) » Definitions » Net Margin %

Comparable Companies

Traded in Other Exchanges

LDXHF:USA

Address

2724 Loker Ave West, Carlsbad, CA, USA, 92010

Website

https://www.lumosdiagnostics.com

Lumos Diagnostics Holdings Ltd is engaged in the development, manufacture and distribution of point-of-care diagnostic (POC) tests and associated readers for analysis of POC diagnostic tests. It also directly develops, manufactures and commercializes proprietary, Lumos-branded POC tests that target infectious and inflammatory diseases. It generates maximum revenue from the commercial services and solutions relating to POC diagnostic tests.

Lumos Diagnostics Holdings (ASX:LDX) Headlines

No Headlines